Search

Your search keyword '"Vascular Cell Adhesion Molecule-1 therapeutic use"' showing total 1 results
Start Over Descriptor "Vascular Cell Adhesion Molecule-1 therapeutic use" Topic carcinoma, renal cell

Refine your results

1 results on '"Vascular Cell Adhesion Molecule-1 therapeutic use"'

1. Endoglin/CD 105 may not be an optimal tumor endothelial treatment target.

Author

Griffioen AW, Damen CA, Blijham GH, and Groenewegen G

Subjects
Animals, Antigens, CD, Carcinoma, Renal Cell drug therapy, Endoglin, Endothelium, Vascular immunology, Female, Humans, Immunotoxins pharmacology, Kidney Neoplasms drug therapy, Mice, Receptors, Cell Surface, Vascular Cell Adhesion Molecule-1 adverse effects, Vascular Cell Adhesion Molecule-1 biosynthesis, Carcinoma, Renal Cell blood supply, Endothelium, Vascular drug effects, Kidney Neoplasms blood supply, Vascular Cell Adhesion Molecule-1 therapeutic use
Published
1996
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results